BMJ Open · 2025-08-22
Potential drug–drug interactions among hospitalised cardiac patients in Nepal: a prospective observational study
Phrase rank #2 · DOI 10.1136/bmjopen-2025-099721
Treatments & interventions
drug
Observed in 123 articles across 28 journals.
Latest share0.22%
Change vs baseline-0.10 pp
Months observed13
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- European Journal of Hospital Pharmacy33
- BMJ28
- BMJ Open7
- Journal for ImmunoTherapy of Cancer6
- Archives of Disease in Childhood4
- BMJ Paediatrics Open4
- Drug and Therapeutics Bulletin4
- Sexually Transmitted Infections4
- Heart3
- Journal of Epidemiology and Community Health3
- Regional Anesthesia & Pain Medicine3
- BMJ Connections Oncology2
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
Journal of Scleroderma and Related Disorders · 2026-06-05
P.259 Advancing drug development for systemic sclerosis by prioritising findings from human genetic association studies
Phrase rank #3 · DOI 10.1136/JSRD-2026-SSWC.302
European Journal of Hospital Pharmacy · 2026-03-18
6ER-041 Observational study of clinical trials involving drug repositioning
Phrase rank #3 · DOI 10.1136/ejhpharm-2026-eahp.641
BMJ · 2026-01-30
When I use a word . . . Artificial intelligence—predicting and detecting adverse drug reactions
Phrase rank #3 · DOI 10.1136/bmj.s154
BMJ Global Health · 2025-11-23
The association between drug shortages and prices across 74 countries: uncovering global access inequities
Phrase rank #3 · DOI 10.1136/bmjgh-2025-018960
BMJ Quality & Safety · 2025-10-17
Psycholinguistic tests predict real-world drug name confusion error rates: a cross-sectional experimental study
Phrase rank #3 · DOI 10.1136/bmjqs-2024-017688
Journal of Epidemiology and Community Health · 2025-08-24
P47 Association between socioeconomic status and high-risk drug classes in older citizens: a nationwide a cohort study
Phrase rank #3 · DOI 10.1136/jech-2025-SSMabstracts.124
BMJ · 2026-06-23
Type 1 diabetes: Drug to delay onset approved for use in the NHS
Phrase rank #4 · DOI 10.1136/bmj-2026-100063
Heart · 2026-06-09
54 Cardiovascular safety of glucagon-like peptide-1 receptor agonists in real-world practice: a comparative phenotype-based analysis
Phrase rank #4 · DOI 10.1136/heartjnl-2026-BCS.237
European Journal of Hospital Pharmacy · 2026-03-18
4CPS-326 Pharmaceutical optimisation of anticonvulsant therapy in critically ill trauma patients
Phrase rank #4 · DOI 10.1136/ejhpharm-2026-eahp.423
Frontline Gastroenterology · 2026-06-29
OC85 Acute drug hypersensitivity reactions to infliximab in paediatric IBD patients: a single centre experience
Phrase rank #5 · DOI 10.1136/flgastro-2026-bspghan.74
Sexually Transmitted Infections · 2026-05-20
P204 From chemsex to a broader drug-sex landscape: comparing two MSM surveys from a Rome STI/HIV reference center
Phrase rank #5 · DOI 10.1136/sextrans-ICAR-2026.162
Drug and Therapeutics Bulletin · 2025-11-16
Ciprofloxacin-induced drug fever
Phrase rank #5 · DOI 10.1136/dtb.2025.266982rep
BMJ Case Reports · 2025-10-17
Ciprofloxacin-induced drug fever
Phrase rank #5 · DOI 10.1136/bcr-2025-266982
BMJ Open Ophthalmology · 2025-10-05
125952 Drug treatments for albinism – on the near horizon?
Phrase rank #5 · DOI 10.1136/bmjophth-2025-BIPOSA.36
BMJ Medicine · 2026-04-22
Current and emerging therapies for pulmonary tuberculosis in adults
Phrase rank #6 · DOI 10.1136/bmjmed-2025-001836
European Journal of Hospital Pharmacy · 2026-01-06
Hospital production of a 1% propofol–cyclodextrin formulation to address drug shortages: a proof of concept
Phrase rank #6 · DOI 10.1136/ejhpharm-2025-004779
BMJ Quality & Safety · 2025-11-19
Effectiveness of computerised alerts to reduce drug–drug interactions (DDIs) and DDI-related harm in hospitalised patients: a quasi-experimental controlled pre–post study
Phrase rank #6 · DOI 10.1136/bmjqs-2024-018243
European Journal of Hospital Pharmacy · 2025-08-21
Improving patient outcomes during cancer drug shortages: the role of patient education
Phrase rank #6 · DOI 10.1136/ejhpharm-2025-004548
European Journal of Hospital Pharmacy · 2026-04-23
Analysis of a serious adverse reaction of rhabdomyolysis precipitated by a possible interaction of methylprednisolone with atorvastatin: a case report
Phrase rank #7 · DOI 10.1136/ejhpharm-2025-004800
European Journal of Hospital Pharmacy · 2026-03-18
2SPD-028 Implementation of ward-based financial monitoring in healthcare management
Phrase rank #7 · DOI 10.1136/ejhpharm-2026-eahp.59
European Journal of Hospital Pharmacy · 2026-03-18
4CPS-088 Pharmacist-led management of sirolimus–voriconazole interaction in a hypoalbuminemic paediatric liver transplant patient: a case report
Phrase rank #7 · DOI 10.1136/ejhpharm-2026-eahp.191
BMJ Connections Oncology · 2026-01-16
Healthcare providers’ knowledge gaps and educational needs in addressing substandard and falsified oncology drugs: a scoping review
Phrase rank #7 · DOI 10.1136/bmjconc-2025-000069
BMJ · 2026-07-15
The beautiful game versus our favourite drug
Phrase rank #8 · DOI 10.1136/bmj-2026-100291
Archives of Disease in Childhood · 2026-05-18
Rethinking the role of out-of-home care in addressing prenatal drug exposure among children
Phrase rank #8 · DOI 10.1136/archdischild-2025-328950
European Journal of Hospital Pharmacy · 2026-03-18
4CPS-004 Intravenous drug incompatibility in the ICU of a university hospital: frequency and the influence of nurses’ years of experience
Phrase rank #8 · DOI 10.1136/ejhpharm-2026-eahp.109
BMJ · 2025-12-05
Drug rollout aimed to show UK still a “science superpower” only reaches 10% of target
Phrase rank #8 · DOI 10.1136/bmj.r2579
Journal for ImmunoTherapy of Cancer · 2025-11-04
174 High-throughput high-plex proteomic profiling of hepatocyte toxicity to oncologic drug compounds: a platform for toxicity assessment, immune risk prediction, and drug development acceleration
Phrase rank #8 · DOI 10.1136/jitc-2025-SITC2025.0174
Journal for ImmunoTherapy of Cancer · 2025-11-04
148 DRUG-seq in CTG3D organoid models: a high-throughput, transcriptomics-driven platform for AI-enhanced drug discovery
Phrase rank #8 · DOI 10.1136/jitc-2025-SITC2025.0148
BMJ · 2026-07-21
Drug industry payments: “Appalling” lack of progress on transparency
Phrase rank #9 · DOI 10.1136/bmj-2026-100357